FindTrial
Sign In

An Observational study to identify the issues and challenges in cancer patients on active treatment during the COVID-19 Pandemic and the resulting Lockdown

An Observational study to identify the issues and challenges in cancer patients on active treatment during the COVID-19 Pandemic and the resulting Lockdown

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2020/05/025070
Enrollment
150
Registered
2020-05-07
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: C00-D49- Neoplasms

Interventions

None listed

Sponsors

MAX SUPER SPECIALITY HOSPITAL
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: i. Registered with the Max Institute of Cancer Care between Nov 1st 2019 to Jan 31st 2020 ii. Were scheduled to receive one or more modalities of treatment (chemotherapy, surgery, radiation therapy, immunotherapy) during the period Feb 1st 2020 to April 30th 2020

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
Our study aims to identify the challenges faced by oncology patients during the pandemic.Timepoint: 09-05-2020 to 30-06-2020—

Secondary

MeasureTime frame
N/ATimepoint: N/A—

Countries

India

Contacts

Public ContactRAJESH SAXENA

Max Super Speciality Hospital Patparganj

Geeta.Kadayaprath@maxhealthcare.com9810169286

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026